Epacria Capital Partners, LLC Clear Point Neuro, Inc. Transaction History
Epacria Capital Partners, LLC
- $120 Billion
- Q2 2025
A detailed history of Epacria Capital Partners, LLC transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Epacria Capital Partners, LLC holds 11,729 shares of CLPT stock, worth $320,436. This represents 0.12% of its overall portfolio holdings.
Number of Shares
11,729Holding current value
$320,436% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding CLPT
# of Institutions
102Shares Held
7.91MCall Options Held
116KPut Options Held
46.8K-
Vanguard Group Inc Valley Forge, PA1.48MShares$40.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA625KShares$17.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY366KShares$10 Million0.0% of portfolio
-
State Street Corp Boston, MA333KShares$9.11 Million0.0% of portfolio
-
Morgan Stanley New York, NY332KShares$9.08 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $669M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...